Hematology Frontier

Editor's Note: In 2025, the International Conference on Malignant Lymphoma (ICML) brought together top global hematologic oncology experts to discuss the latest advancements and future trends in lymphoma treatment. During…

Editor's Note: At a highly anticipated hematologic oncology conference, the Late-Breaking Abstract (LBA) session became a focal point. Co-chaired by Professor Kim Linton from the University of Manchester and Professor…

Editor's Note: The global oncology community continues to focus on cutting-edge breakthroughs in lymphoma treatment. At an important academic conference, Professor Maruyama from Keio University Hospital in Tokyo, Japan, presented…

Editor's Note: At this conference, Professor Alexey Danilov (Professor of Hematology, Associate Director of the Lymphoma Center, and Director of the Early Therapeutics Program at City of Hope National Medical…

Editor's Note: At ICML conference, Professor Jose C. Villa Boas from Rochester, USA, was invited to present an oral report titled "EO2463 Peptide Immunotherapy in Combination with Lenalidomide and Rituximab…

Editor's Note: The conference brought together top experts in lymphoma research from home and abroad, engaging in in-depth discussions on cutting-edge topics such as novel molecular targeted therapies and cell…

Editor's Note: The 18th International Conference on Malignant Lymphoma (ICML) was held, gathering top experts in the lymphoma field in Lugano. At the prestigious John Ultmann Memorial Lecture, Professor Emanuele…

Editor's Note: In 2025, the International Conference on Malignant Lymphoma (ICML) convened in Switzerland, bringing together the world's leading experts in the field of lymphoma. At the conference, Professor David…

Editor's Note: The International Hematologic Oncology Pathology Conference brought together top experts in hematopathology research from home and abroad for in-depth discussions on cutting-edge topics such as lymphoma diagnosis, classification…